ThursdayMar 26, 2020 1:11 pm

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Establishing Foothold in China’s Rising CBD Market

ChineseInvestors.com (OTCQB: CIIX) is leveraging its financial expertise to establish itself as a leader in China’s emerging cannabidiol (“CBD”) market. CIIX CEO Warren Wang recently discussed the potential health benefits offered by the company’s CBD-based products in an interview with MoneyTV’s Donald Baillargeon (http://cnw.fm/V4vSv). An article discussing the company reads, “Speaking about CIIX’s current efforts to promote the power of CBD oil, Wang announced that the company entered a deal with Vitamist, an organization that produces premium-quality supplements for health-conscious consumers. ‘Our company is very helpful for Chinese people,’ added Wang. ‘I see tremendous opportunities here within the next three to…

Continue Reading

FridayMar 20, 2020 12:29 pm

CBDNewsBreaks – Pressure BioSciences Inc.’s (PBIO) UST Demonstration Laboratory Showcases Groundbreaking Technology

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the worldwide life sciences and other industries, recently announced the opening of its new Ultra Shear Technology(TM) (“UST”) Demonstration Laboratory (http://cnw.fm/zGUb0). An article discussing the company reads, “The main goal of the UST Demo Lab is to showcase the ability of the company’s revolutionary UST Platform to process cannabidiol (‘CBD’) oil into water-soluble nanoemulsions of superior quality. CBD nanoemulsions are expected to be more stable and offer higher bioavailability than the standard macro and microemulsions used in the vast majority…

Continue Reading

FridayMar 20, 2020 10:37 am

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Launches Media Campaign to Highlight Benefits of CBD Oil

ChineseInvestors.com (OTCQB: CIIX) CEO Warren Wang recently announced the launch of a media campaign to raise awareness of the benefits of CBD oil during an interview on “MoneyTV” (http://cnw.fm/gAtd3). An article discussing the company reads, “During his interview with ‘MoneyTV’ host Donald Baillargeon, Wang said the purpose of the media campaign is to raise awareness — and ultimately sales — of CBD oil products offered by CBD Biotech. . . .‘We will have an infomercial in an AM radio show in China for one month to start to create an awareness campaign to explain the benefits of CBD oil and…

Continue Reading

FridayMar 06, 2020 3:15 pm

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Subsidiary Leveraging Fully Legal, Hemp-Based CBD Product Market in China

ChineseInvestors.com (OTCQB: CIIX) is taking advantage of the legal hemp-based CBD market in China through increased product development and positioning its CBD Biotech Inc. subsidiary as a market leader. An article discussing the company reads, “With few competitors and plenty of room for market dominance, CIIX plans to seize opportunities in the fully legal, hemp-based CBD nutritional and cosmetic product markets in China. While cannabis is still illegal in the country, prohibitory laws do not apply to hemp-based CBD cosmetics. Unaffected by changing regulations, CIIX is able to operate in a stable environment with the freedom to focus investment on…

Continue Reading

MondayFeb 24, 2020 3:14 pm

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Ahead of Curve in China’s CBD Market

ChineseInvestors.com (OTCQB: CIIX) is employing its financial proficiency to establish itself as a leader in China’s emerging cannabidiol (“CBD”) industry. An article discussing the company reads, “Although cannabis is currently illegal in China, hemp-based CBD can be legally added to nutrition and health products and cosmetics, opening up massive opportunities in the untapped Chinese CBD market. CIIX has created a three-year development plan to pioneer an attractive lineup of CBD-based products through its subsidiary, CBD Biotech, and capitalize on the tremendous potential of the enormous Chinese market, where the benefits of CBD oil have not been widely recognized yet. .…

Continue Reading

FridayFeb 21, 2020 2:16 pm

CBDNewsBreaks – HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Targets Cannabinoid Extract Industry

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) is a hemp-biomass cultivation, extraction, formulation and refining entity that utilizes its trademarked Delta Reclaiming System technologies to limit CBD waste. A recent article discussing the company reads, “HTC Extraction Systems’ working relationships with other cannabinoid industry players further shore up its revenues possibilities. Most recently, the Canadian company closed its acquisition of a California-based company in the United States. The recently acquired Kase Farma Inc. is authorized to work with hemp cultivation, extraction, refining, formulation and business operations in the world’s largest cannabinoid market (http://cnw.fm/vl8KO), and HTC Extraction will reap the experience of…

Continue Reading

FridayFeb 21, 2020 2:10 pm

CBDNewsBreaks – MCTC Holdings Inc. (MCTC) Provides Improved CBD-Infusion Method for Single-Serving Coffee Manufacturers

MCTC Holdings (OTC: MCTC), a research and development company deploying new extraction and infusion technologies for the cannabinoid and hemp industries, recently announced production of its new Hemp You Can Feel(TM) Coffee Infusions tablets and powders that enable food and beverage manufacturers to efficiently infuse their products. An article discussing the company reads, “MCTC’s Hemp You Can Feel(TM) Coffee Infusions are available either as a tablet containing cannabinoid infusions that can be added to coffee pods on a customer-customized basis, or as a cannabinoid powder for manufacturers with automated capabilities. . . .‘We are now offering single-serving coffee manufacturers a…

Continue Reading

TuesdayFeb 18, 2020 2:06 pm

CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Strikes Licensing Deal with Cannadips CBD

British Columbia-based Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently entered a definitive agreement to provide its patented DehydraTECH(TM) technology to Cannadips CBD. An article discussing the company reads, “The agreement announced recently provides Cannadips CBD with exclusive access rights to Lexaria’s technology for the U.S. market for 10 years, granting the ‘Original Smokeless CBD Dip Brand’ Lexaria’s fast-acting, high-absorption technology with options to expand the license to Europe, Mexico, and Canada and to renew the license for an additional five years (http://cnw.fm/V6p4Q). . . . ‘This combination of superior science from Lexaria and a unique and strong branded proposition that Cannadips…

Continue Reading

ThursdayFeb 13, 2020 3:21 pm

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Pursuing Untapped Chinese CBD Market

ChineseInvestors.com (OTCQB: CIIX), a financial news media and content platform that provides information to the global Chinese-speaking community, plans to expand its customer base with new hemp-based CBD products in 2020. Through CIIX’s CBD Biotech subsidiary, CEO Warren Wang plans to capitalize on the massive potential of the untapped Chinese CBD market. An article discussing the company reads, “Wang noted that China’s changing CBD laws can create volatility for CBD companies. However, those laws don’t apply to hemp-based CBD cosmetics, which are fully legal in China, Japan and the United States. Because CIIX is only involved in CBD cosmetics, the…

Continue Reading

ThursdayFeb 13, 2020 3:16 pm

CBDNewsBreaks – HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Targets Booming Hemp-Based CBD Products Market

Hemp biomass cultivation, extraction, formulation and refining entity HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) is slated for market growth through 2020 as the U.S. hemp-based, CBD-products market continues to flourish. A recent article discussing the company reads, “Overall, HTC Extraction Systems has a highly optimistic outlook when it comes to its extraction market expansion, where it is already a key player. The company expects a wealth of opportunities for growth in the near future, given the rapid expansion of the cannabinoid market as a whole. U.S. sales of hemp-based CBD products are projected to reach $22 billion by 2022,…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722